PTSM: Pharmaceutical Technology Sourcing and Management, Apr 30, 2007 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PTSM: Pharmaceutical Technology Sourcing and Management, Apr 30, 2007
Global Feature
Pharmaceutical Benchmarking: A Contract Manufacturing Perspective
By Shane Ernst
The author analyzes the study design, participation, and data pooling from a recent benchmarking study on pharmaceutical manufacturing and raises concerns about the process used and data collected in evaluating the performance of contract manufacturers.
Pharma Partner Focus
Ricerca Unveils Growth Strategy
By Patricia Van Arnum
Ricerca Biosciences LLC a contract drug-development company, is embarking on a growth strategy upon which it hopes to double its revenues by 2009. The company recently completed a financial restructuring that includes new equity and term facilities totaling nearly $50 million. That financing will enable Ricerca to implement a multiyear business plan, which includes a $15-million investment to add chemistry and biological laboratories to its site in Concord, Ohio.
Outsourcing
Project Managers in the Spotlight
By Jim Miller
Strong demand is straining service providers' project-management capabilities; Patheon receives a much-needed cash infusion.
News
Agreements and contracts
The latest pacts from the pharmaceutical supply chain.
Regulatory and association news
The latest regulatory and association news for pharmaceutical manufacturers and contract manufacturing organizations.
People
People on the move.
Mergers, acquisitions, and restructuring
A roundup of company moves and positioning from the pharmaceutical industry and biotechnology industries and contract service providers.
Expansions
A roundup of manufacturing and service expansions for April 2007.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Click here